Article

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

2019-09-01

Abstract excerpt

No abstract is available from the source.

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: add4d784-76eb-526f-a6d1-0364a8fabeac
DOI: 10.1016/j.cmet.2019.08.002

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseDOI 10.1016/j.cmet.2019.08.002Read

Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Current Concepts, Opportunities, and Challenges of Gut Microbiome-Based Personalized Medicine in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

The Intestinal Microbiome in Nonalcoholic Fatty Liver DiseaseSemantic proximity Read

Gut microbiota and human NAFLD: disentangling microbial signatures from metabolic disordersSemantic proximity Read

The links between the gut microbiome and non-alcoholic fatty liver disease (NAFLD)Semantic proximity Read

Fecal Metagenomics and Metabolomics Identifying Microbial Signatures in Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read

Multi-omics analysis reveals the impact of microbiota on host metabolism in hepatic steatosisSemantic proximity Read

Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver DiseaseSemantic proximity Read

Links between gut microbiome composition and fatty liver disease in a large population sampleSemantic proximity Read

Disentangling the Progression of Non-alcoholic Fatty Liver Disease in the Human Gut MicrobiotaSemantic proximity Read